~~<i id='69F3AA1CD5'><strike id='69F3AA1CD5'><tt id='69F3AA1CD5'><pre id='69F3AA1CD5'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

leisure time

author：explore 2025-09-06 05:03:03 - browse：96

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Some of the ways extreme heat will change life as we know it

hotspot

focus

entertainment

focus

hotspot

entertainment

STATWhencomedian JohnOliver tookpharmacompaniestotask onhisHBOshowSundayfortheirmarketingofpowerfuln

WSS

'Patient friction coefficient' can gauge a clinical trial's patient burden

TB outbreak tied to bone grafts underscores testing shortcomings

House GOP releases memo on Hunter Biden foreign business dealings, reviving old claims

White House drug shortages task force keeps mum with Congress

Novo acquires Inversago for up to $1 billion

Newly revealed memo details efforts to keep Trump in power following election loss

focus

leisure time

hotspot

BioMarin wins approval for gene therapy to treat hemophilia A

Erich Jarvis studies song birds to learn about human stuttering

Peter Hotez and the public health issue of online harassment

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Duchenne breakthrough therapy leaves behind pioneering families

Target recalls 2.2 million additional candles due to laceration, burn hazards

Hepatitis C has a cure — but many Americans still lack access to it

Pregnancy ages women, but effects reverse after delivery

Drug repurposing or repositioning? The language matters

Biotech investment managers search for lucrative opportunities

focus

Novo Nordisk to buy Cardior, building up pipeline of heart drugs

Some of the ways extreme heat will change life as we know it

An innovative path out of biotech’s “valley of death”

The history of OxyContin, told through Purdue Pharma documents

CRISPR technology availability, affordability needs to be expanded

TB outbreak tied to bone grafts underscores testing shortcomings

entertainment

focus

hotspot

entertainment